Related Experiment Videos
Acute intermittent porphyria complicated by pregnancy
1Department of Obstetrics and Gynaecology, Huddinge University Hospital, Karolinska Institute, Sweden.
Clinical and Experimental Obstetrics & Gynecology
|January 1, 1988
Summary
Pregnancy can worsen acute intermittent porphyria (AIP), leading to complications like premature birth and intrauterine growth retardation. Careful monitoring and management are crucial for affected mothers and their infants.
Area of Science:
- Medicine
- Genetics
- Obstetrics
Background:
- Acute intermittent porphyria (AIP) is a rare genetic disorder affecting heme synthesis.
- Pregnancy presents unique physiological challenges that can impact chronic conditions.
- The interplay between AIP and pregnancy requires careful consideration for maternal and fetal well-being.
Observation:
- A case study details a woman experiencing two pregnancies with AIP.
- Both pregnancies were associated with significant exacerbations of her AIP symptoms.
- Intrauterine growth retardation necessitated premature delivery for both infants.
Findings:
- The first infant succumbed to respiratory distress syndrome post-delivery.
- The second infant exhibited transient abstinence symptoms, linked to maternal pethidine use during gestation.
- Pregnancy demonstrably exacerbates acute intermittent porphyria, posing risks to both mother and child.
Implications:
- This case highlights the critical need for specialized obstetric and medical management in pregnant women with AIP.
- Understanding the impact of pregnancy on AIP can inform clinical guidelines and improve patient outcomes.
- Further research into managing AIP during pregnancy is warranted to mitigate risks and optimize infant health.